C9 and amyotrophic lateral sclerosis: Testing of post-mortem tissues from ALS/FTD patients has not shown a correlation between the amount or localization of C9-DRPs and neurodegenerative phenotype, which contributes to skepticism that C9-DRPs are the major contributor to C9-ALS/FTD pathogenesis [27].